Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review
- PMID: 30791881
- PMCID: PMC6385454
- DOI: 10.1186/s12885-019-5355-4
Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review
Abstract
Background: The association of ABO blood groups with gastric cancer risk was proposed decades ago, but the results have been inconsistent.
Methods: We used two single nucleotide polymorphisms to determine ABO genotype in 4932 gastric cancer cases and 6158 controls of Chinese descent, and evaluated the associations of ABO blood groups and genotypes with risk of gastric cancer using multivariable logistic regression models. We also systematically reviewed published literature and performed a meta-analysis of all relevant studies.
Results: In the case-control study, compared with blood group O, both blood group A and AB were associated with increased gastric cancer risk (for group A, odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.02-1.24; for group AB, OR = 1.18, 95% CI: 1.02-1.36, respectively). Analyses of ABO genotypes revealed associations of AO and AB with risk of gastric cancer compared with OO genotype. Consistent with the case-control study, meta-analysis of 40 studies including 33,613 cases and 2,431,327 controls demonstrated that blood group A (OR = 1.19, 95% CI: 1.13-1.25) and AB (OR = 1.09, 95% CI: 1.03-1.16) were associated with increased risk of gastric cancer.
Conclusions: Our analyses validated the association of blood group A with risk of gastric cancer, and suggested that blood group AB was also associated with gastric cancer risk. Functional investigations are warranted to elucidate the exact mechanism of ABO blood groups in gastric carcinogenesis.
Keywords: ABO blood group system; Case-control study; Gastric cancer; Meta-analysis; Systematic review.
Conflict of interest statement
Ethics approval and consent to participate
The current study was approved by the Institutional Review Boards of Nanjing Medical University and Ningxia Medical University. Specifically, for Cohort I, written informed consent was obtained from each participant, and the study was approved by the Institutional Review Boards of all participating institutions. For Cohort II, participants were derived from the United States National Cancer Institute (NCI) GWAS, and each of the five participating studies obtained informed consent from participants and from their studies Institutional Review Board(s). The NCI Special Studies-Institutional Review Board approved the overall GWAS study. For Cohort III, the study was approved by the Institutional Review Board of Ningxia Medical University and Nanjing Medical University, and written informed consent was obtained for each participant. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and later versions.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
ABO genotypes and the risk of esophageal and gastric cancers.BMC Cancer. 2021 May 22;21(1):589. doi: 10.1186/s12885-021-08334-1. BMC Cancer. 2021. PMID: 34022824 Free PMC article.
-
Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population.Gastric Cancer. 2013 Apr;16(2):254-60. doi: 10.1007/s10120-012-0176-z. Epub 2012 Aug 3. Gastric Cancer. 2013. PMID: 22865192
-
Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.Cancer Res. 2010 Feb 1;70(3):1015-23. doi: 10.1158/0008-5472.CAN-09-2993. Epub 2010 Jan 26. Cancer Res. 2010. PMID: 20103627 Free PMC article.
-
ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis.Am J Epidemiol. 2013 Jun 15;177(12):1326-37. doi: 10.1093/aje/kws458. Epub 2013 May 6. Am J Epidemiol. 2013. PMID: 23652164 Free PMC article.
-
Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis.Gene. 2019 Feb 15;685:125-135. doi: 10.1016/j.gene.2018.10.077. Epub 2018 Nov 1. Gene. 2019. PMID: 30391440
Cited by
-
Role of MiRNA in the Regulation of Blood Group Expression.Transfus Med Hemother. 2024 Jun 4;51(4):237-251. doi: 10.1159/000538866. eCollection 2024 Aug. Transfus Med Hemother. 2024. PMID: 39135851 Free PMC article. Review.
-
Investigation of unfavorable prognostic factors for survival in Chinese patients with gastric gastrointestinal stromal tumors.Transl Cancer Res. 2024 Dec 31;13(12):6782-6792. doi: 10.21037/tcr-24-1042. Epub 2024 Dec 27. Transl Cancer Res. 2024. PMID: 39816539 Free PMC article.
-
ABO genotypes and the risk of esophageal and gastric cancers.BMC Cancer. 2021 May 22;21(1):589. doi: 10.1186/s12885-021-08334-1. BMC Cancer. 2021. PMID: 34022824 Free PMC article.
-
Novel evidence that the ABO blood group shapes erythropoiesis and results in higher hematocrit for blood group B carriers.Leukemia. 2023 May;37(5):1126-1137. doi: 10.1038/s41375-023-01858-4. Epub 2023 Feb 28. Leukemia. 2023. PMID: 36854778 Free PMC article.
-
The Association Between ABO Blood Group and Preeclampsia: A Systematic Review and Meta-Analysis.Front Cardiovasc Med. 2021 Jun 21;8:665069. doi: 10.3389/fcvm.2021.665069. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34235185 Free PMC article.
References
-
- Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N: Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control : CCC 2008, 19(7):689–701. - PubMed
-
- Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P. A meta-analysis on alcohol drinking and gastric cancer risk. Annals of oncology : official journal of the European Society for Med Oncol. 2012;23(1):28–36. doi: 10.1093/annonc/mdr135. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 2016YFC1302703/the National major Research and Development Program
- 81602917/National Natural Science Foundation of China
- 81872702, 81521004/National Natural Science Foundation of China
- 15KJA330002/Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions
- PPZY2015A067/Top-notch Academic Programs Project of Jiangsu Higher Education Institutions
- 201-30181601/West China First-class Discipline Construction Project in Basic Medicine funded by Ningxia Medical University
- No.2018YCGC003/The Talent Project of Zhejiang Association for Science and Technology
- BRA2018057/333 High-Level Talents Cultivation Project of Jiangsu Province
- LQ15H260001/Zhejiang Provincial Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical